Publication: Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
No Thumbnail Available
Identifiers
Date
2018
Authors
Martínez-Cuadrón, David
Boluda, Blanca
Martínez, Pilar
Bergua, Juan
Rodríguez-Veiga, Rebeca
Esteve, Jordi
Vives, Susana
Serrano, Josefina
Vidriales, Belen
Salamero, Olga
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
The name of Pau Montesinos was inadvertently presented as Pau Montesinos Fernández in the original article.The original version of this article was revised: The name of Pau Montesinos was inadvertently presented as Pau Montesinos Fernández.